Ipamorelin

Overview

Ipamorelin is a selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin.

Mechanism
May support:
Candidate Considerations
Safety

Compounded ipamorelin is prescribed only after medical evaluation and is not FDA-approved for disease treatment.

Consultation

Initial consultation: $99

Frequently Asked Questions

Ipamorelin is not FDA-approved for disease treatment and is available only through compounded prescriptions.

It may be legally prescribed by a licensed physician when clinically appropriate.

Ipamorelin is typically administered via subcutaneous injection, often in the evening.

Patients with certain endocrine disorders or medical conditions should be evaluated before use.

Verified by MonsterInsights